Foldesy R G, Homm R E, Levinson S L, Hahn D W
Fertil Steril. 1986 Apr;45(4):550-5. doi: 10.1016/s0015-0282(16)49286-1.
ORF 13904, a sulfonated polystyrene polymer possessing potent vaginal contraceptive activity, was tested in vitro and in vivo to investigate its mechanism of action. Observations of rabbit spermatozoa when mixed with the compound in buffered saline confirmed that the compound is not spermicidal and showed that the cells rapidly and irreversibly agglutinate. Seminal plasma did not compromise the effects of the drug, but rather enhanced them. When spermatozoa were suspended in solutions containing ORF 13904 and then washed thoroughly to remove excess drug, human spermatozoa could not penetrate bovine cervical mucus in vitro and rabbit spermatozoa could not achieve fertilization after artificial insemination in vivo, suggesting that the drug either adheres to the sperm surface or irreversibly compromises sperm function. Biochemical analysis showed that ORF 13904 is also a potent acrosin inhibitor. These experiments suggest that ORF 13904 has several mechanisms of action, including the ability to agglutinate spermatozoa, alter sperm-cervical mucus interaction, and inhibit sperm acrosin.
ORF 13904是一种具有强大阴道避孕活性的磺化聚苯乙烯聚合物,在体外和体内进行了测试,以研究其作用机制。在缓冲盐水中将兔精子与该化合物混合后进行观察,证实该化合物无杀精作用,并表明细胞会迅速且不可逆地凝集。精浆不会削弱药物的作用,反而会增强其作用。当精子悬浮在含有ORF 13904的溶液中,然后彻底洗涤以去除过量药物时,人类精子在体外无法穿透牛宫颈黏液,兔精子在体内人工授精后无法受精,这表明该药物要么粘附在精子表面,要么不可逆地损害精子功能。生化分析表明,ORF 13904也是一种有效的顶体蛋白酶抑制剂。这些实验表明,ORF 13904有多种作用机制,包括凝集精子、改变精子与宫颈黏液的相互作用以及抑制精子顶体蛋白酶的能力。